No evidence of sexual transmission of HEV among individuals using HIV pre‐exposure prophylaxis
- 2 August 2020
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 27 (12) , 1495-1501
Abstract
We investigated the seroprevalence and incidence of hepatitis E virus (HEV) infection in men who have sex with men (MSM) who have been exposed to pre‐exposure prophylaxis (PrEP) against HIV as sexual transmission of HEV has been suggested. A total of 147 PrEP‐using MSM and 147 blood donors matched for sex, age and geographical area were tested for anti‐HEV IgG and IgM. Among them, 135 have been followed for 1 year, at the end of which serological tests for HEV were performed retrospectively on stored samples. Laboratory data on sexual transmitted infections (STIs) and viral hepatitis, including hepatitis A virus (HAV), were collected. Baseline seroprevalence rates in PrEP users were 42.2% (anti‐HEV IgG) and 3.4% (anti‐HEV IgM). Those of the control blood donors were similar (anti‐HEV IgG 43.5% and anti‐HEV IgM 4.1%). There was no incident of HEV infection despite the rates of bacterial STIs (incidence rate (IR) = 46.6%) and HAV infection (IR = 15.8%). Age was the only risk factor associated with anti‐HEV IgG seropositivity at baseline and at the end of follow‐up. Sexual transmission does not seem to be a major route of HEV infection in MSM, unlike HAV.Keywords
This publication has 30 references indexed in Scilit:
- Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patientsJournal of Clinical Virology, 2013
- Hepatitis E Virus Seroprevalence among Men Who Have Sex with Men, United KingdomEmerging Infectious Diseases, 2013
- Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIVJournal of Infection, 2013
- Test Performance Characteristics of Anti-HEV IgG Assays Strongly Influence Hepatitis E Seroprevalence EstimatesThe Journal of Infectious Diseases, 2012
- Hepatitis E virus infection in patients infected with the human immunodeficiency virusJournal of Medical Virology, 2011
- Hepatitis E virus coinfection in patients with HIV infectionHIV Medicine, 2011
- Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, FranceEmerging Infectious Diseases, 2011
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialThe Lancet, 2010
- A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countriesJournal of Medical Virology, 2010
- Hepatitis E Virus Genotype 3 Diversity, FranceEmerging Infectious Diseases, 2009